CD276 and neoplasm: In a preclinical model of AT/RT tumours, the intraventricular or intratumoral administration of B7-H3 CAR T cells had a higher antitumour effect and reduced systemic levels of inflammatory cytokines when compared to CAR T cells administered intravenously [150].